Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata is a chronic condition causing hair loss, with new treatments targeting the immune system showing promise.

Early immunosuppressive therapy leads to favorable outcomes in Filipino lupus patients with myocarditis.

Oral lichen planus is a chronic disease causing mouth discomfort and sometimes needs immunosuppressive treatment.

Permanent makeup can cause delayed allergic reactions, but they can be managed with proper treatment.

A rare autoimmune condition, Satoyoshi syndrome, can start in adults and improve with immunosuppressive treatment.

Diphenylcyclopropenone (DPCP) effectively treated both alopecia areata and verruca vulgaris.

The document suggests a personalized treatment plan for alopecia areata based on the patient's age and hair loss severity, using a range of therapies ranked by effectiveness and safety.

Methotrexate is a promising and safe treatment for severe alopecia areata, with better results when combined with corticosteroids.

Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.

Bullous lupus can cause severe esophageal issues but responds well to corticosteroids and azathioprine.

Early diagnosis and treatment are crucial for CAPS, and Eculizumab can be effective.

Lupus pneumonitis can be misdiagnosed as pneumonia or tuberculosis, so consider lupus in similar cases for proper treatment.

Certain medications can reduce mortality risk in COPD patients, but others can increase risks of cardiovascular issues, postoperative delirium, and other adverse effects.

Azathioprine may help treat severe alopecia areata, but more research is needed.

Anifrolumab helped some lupus patients reduce steroid use, but safety concerns remain.

There is no cure for alopecia areata, but treatments like JAK inhibitors show promise.

Home-use lasers and IPL devices are unlikely to directly cause paradoxical hair growth; it may be linked to inflammation or hormonal issues.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

Japanese patients and physicians often disagree on the severity of Alopecia Areata and treatment satisfaction, needing better communication and treatments.

Proper diagnosis and treatment of childhood hair loss require distinguishing between alopecia and trichotillomania.

New regenerative treatments for hair loss show promise but need more research for confirmation.

AKN is a chronic scalp condition in African-descended males, treated with topicals, antibiotics, steroids, and sometimes surgery or laser.

308-nm excimer light therapy helped over a third of treatment-resistant alopecia universalis patients regrow most of their hair.

Proactive physical therapy improved mobility, reduced fatigue, and pain in lupus patients.

Some herbal therapies may help with skin conditions, but more research is needed to confirm their safety and effectiveness.

Topical corticosteroids may be a safe and effective treatment for severe alopecia areata in children.

Combining systemic steroids and dithranol can effectively regrow hair in severe alopecia areata.

Using minoxidil on the scalp can help grow hair for people with hereditary baldness.

The alexandrite laser effectively reduces unwanted hair by about 75%.

High potency topical steroids are the most effective treatment for pediatric alopecia areata.